Skip to Main Content

Paper Details

Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors.
Blood
49
2021
CAT, CDKN2B, CTNNB1, KEAP1, KRAS, MET, SETD2, STK11, Tumor, VTE, Venous thromboembolism, cancer, cancer-associated pulmonary embolism, patients, proximal/distal lower extremity deep vein thrombosis, solid tumor, solid tumors, tumor

Datasets

Release 1.2